文献速递心力衰竭与心肌病

多维变异效应规模化检测揭示肥厚型心肌病序列-功能关系

Scaled Multidimensional Assays of Variant Effect Identify Sequence-Function Relationships in Hypertrophic Cardiomyopathy.
PubMed 文献 · Circulation · 2026-07-12

研究开发了一种规模化多维映射策略,在人类诱导多能干细胞来源心肌细胞中,结合饱和碱基编辑、长读长RNA测序剪接 assay 及HCM相关表型测量,对MYBPC3基因关键结构域变异进行功能分析。结果显示cMyBP-C丰度降低是HCM相关表型的关键驱动因素,蛋白降解下调与MYBPC3功能丧失相关,贝叶斯变异效应估计可实现临床变异重分类。

要点

  • 多维功能检测可对MYBPC3变异进行高分辨率功能分析并重分类临床变异
  • cMyBP-C丰度降低是HCM相关表型的关键驱动因素
  • 蛋白降解下调与MYBPC3功能丧失相关,近关键结合域的错义变异存在新致病机制

核心结论

  • 规模化多维变异效应检测平台可提升对变异致病性的理解并揭示新的生物学机制。
  • 贝叶斯变异效应估计能够实现临床变异的重分类。

研究设计与样本

  • 开发规模化多维映射策略,在天然MYBPC3位点进行饱和碱基编辑。
  • 采用长读长RNA测序检测变异剪接效应,并在人诱导多能干细胞来源心肌细胞中测量HCM相关表型。

主要发现

  • 大规模并行剪接 assay 识别出新的剪接破坏性变异。
  • 靶向瞬时碱基编辑在天然位点生成全面变异文库,捕获对HCM相关细胞表型的不同效应。
  • 功能 assay 整合显示cMyBP-C丰度降低是HCM相关表型的关键驱动因素。
  • 蛋白降解下调与MYBPC3功能丧失相关,近关键结合域的错义变异存在新潜在疾病机制。

临床怎么用

  • 该平台可用于对MYBPC3变异进行功能解读,辅助临床变异重分类。
  • cMyBP-C丰度与蛋白降解通路可作为HCM相关机制研究与治疗策略开发的参考方向。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: An estimated 1 in 500 people lives with hypertrophic cardiomyopathy (HCM), a disease for which genetic diagnosis can identify family members at risk and increasingly guide therapy. Variants in the MYBPC3 gene, which encodes cardiac myosin-binding protein C (cMyBP-C), account for a significant proportion of HCM cases. However, many of these are classified as variants of uncertain significance, complicating clinical decision-making. Scalable methods for variant interpretation in disease-specific cell types are crucial for understanding variant impact and uncovering disease mechanisms. METHODS: We developed a scaled multidimensional mapping strategy to evaluate the functional impact of variants across a critical domain of cMyBP-C. We incorporate saturation base editing at the native MYBPC3 locus, a long-read RNA sequencing-enabled assay of variant splice effects, and measurements of HCM-relevant phenotypes, including cMyBP-C abundance, hypertrophic signaling, and ubiquitin-proteasome function in human induced pluripotent stem cell-derived cardiomyocytes. RESULTS: Our multidimensional mapping strategy enabled high-resolution functional analysis of MYBPC3 variants in induced pluripotent stem cell-derived cardiomyocytes. Our massively parallel splicing assay identified novel splice-disrupting variants. Targeted transient base editing generated a comprehensive variant library at the native locus, capturing diverse variant effects on cellular HCM-relevant phenotypes. Integration of functional assays revealed that decreased cMyBP-C abundance is a key driver of HCM-related phenotypes. In parallel, downregulation of protein degradation was observed to correlate with MYBPC3 loss of function, and novel potential disease mechanisms were identified for missense variants near a critical binding domain. Bayesian estimates of variant effects enable the reclassification of clinical variants. CONCLUSIONS: This work provides a platform for extending genome engineering in induced pluripotent stem cells to multiplexed assays of variant effects across diverse disease-relevant cellular phenotypes, enhancing our understanding of variant pathogenicity and uncovering novel biological mechanisms that could inform therapeutic strategies.

来源:Circulation,查看原文。版权归原作者所有。

引用

  1. Yamamoto Y, Chua K, Staudt D, et al. Scaled Multidimensional Assays of Variant Effect Identify Sequence-Function Relationships in Hypertrophic Cardiomyopathy. Circulation. 2026. PMID: 42437345. doi:10.1161/CIRCULATIONAHA.125.075535

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。